Physician profile
William Harris
NPI 1578250171
$472.42
in general payments reported to CMS, 2019-2025
14 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.89 · 2024: $233 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $89.78 | 2024-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $60.53 | 2025 | Ozempic |
| Phathom Pharmaceuticals, INC. | $49.53 | 2024 | Voquezna |
| Abbvie INC. | $46.02 | 2025 | |
| Xeris Pharmaceuticals, INC. | $40.50 | 2024 | Recorlev |
| Amgen INC. | $33.61 | 2024-2025 | Otezla, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $31.78 | 2023-2024 | Breztri, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.30 | 2024-2025 | Xifaxan, Trulance |
| Emd Serono, INC. | $17.55 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.20 | 2025 | Caplyta |
| Lilly USA, LLC | $16.00 | 2024 | Jardiance |
| Exact Sciences Corporation | $13.84 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $13.66 | 2025 | Arexvy, Shingrix |
| Pfizer INC. | $13.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.